We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
+7.46%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$29.6B
AUM Growth
+$2.54B
Cap. Flow
+$740M
Cap. Flow %
2.5%
Top 10 Hldgs %
36.41%
Holding
1,385
New
83
Increased
652
Reduced
368
Closed
52

Top Buys

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$163M
2
NOW icon
ServiceNow
NOW
+$139M
3
ELS icon
Equity Lifestyle Properties
ELS
+$137M
4
CCI icon
Crown Castle
CCI
+$118M
5
NFLX icon
Netflix
NFLX
+$115M

Top Sells

Rank Stock Value
1
KRMA
Global X Conscious Companies ETF
KRMA
+$130M
2
SUI icon
Sun Communities
SUI
+$123M
3
SBAC icon
SBA Communications
SBAC
+$108M
4
MAA icon
Mid-America Apartment Communities
MAA
+$77.2M
5
WELL icon
Welltower
WELL
+$73M

Sector Composition

Rank Sector Weight
1 Technology 30%
2 Real Estate 28.67%
3 Communication Services 10.86%
4 Consumer Discretionary 6.91%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XLV icon
1201
State Street Health Care Select Sector SPDR ETF
XLV
$43.2B
$5K ﹤0.01%
33
– –
ZLAB icon
1202
Zai Lab
ZLAB
$2.05B
$5K ﹤0.01%
150
-43
-22% -$1.48K
ZYME icon
1203
Zymeworks
ZYME
$1.69B
$5K ﹤0.01%
286
– –
AMLX icon
1204
Amylyx Pharmaceuticals
AMLX
$2.17B
$4K ﹤0.01%
266
– –
AMPH icon
1205
Amphastar Pharmaceuticals
AMPH
$903M
$4K ﹤0.01%
135
-50
-27% -$1.29K
ARDX icon
1206
Ardelyx
ARDX
$1.25B
$4K ﹤0.01%
754
– –
COLL icon
1207
Collegium Pharmaceutical
COLL
$1.17B
$4K ﹤0.01%
127
– –
CVAC
1208
DELISTED
CureVac
CVAC
$4K ﹤0.01%
697
– –
DVAX
1209
DELISTED
Dynavax Technologies
DVAX
$4K ﹤0.01%
409
– –
GRFS
1210
Grifois
GRFS
$5.59B
$4K ﹤0.01%
398
– –
INVA icon
1211
Innoviva
INVA
$1.61B
$4K ﹤0.01%
238
– –
NVAX icon
1212
Novavax
NVAX
$1.21B
$4K ﹤0.01%
492
-160
-25% -$1.25K
PCRX icon
1213
Pacira BioSciences
PCRX
$1.06B
$4K ﹤0.01%
169
– –
SPRY icon
1214
ARS Pharmaceuticals
SPRY
$558M
$4K ﹤0.01%
367
– –
STOK icon
1215
Stoke Therapeutics
STOK
$1.84B
$4K ﹤0.01%
175
– –
TXG icon
1216
10x Genomics
TXG
$6.04B
$4K ﹤0.01%
370
– –
USIG icon
1217
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.4B
$4K ﹤0.01%
80
-33
-29% -$1.7K
WVE icon
1218
Wave Life Sciences
WVE
$1.13B
$4K ﹤0.01%
503
– –
XLF icon
1219
State Street Financial Select Sector SPDR ETF
XLF
$57.1B
$4K ﹤0.01%
72
– –
LENZ
1220
LENZ Therapeutics
LENZ
$185M
$4K ﹤0.01%
91
– –
RAPP
1221
Rapport Therapeutics
RAPP
$2.03B
$4K ﹤0.01%
121
– –
ANAB icon
1222
AnaptysBio
ANAB
$1.56B
$3K ﹤0.01%
105
– –
AQST icon
1223
Aquestive Therapeutics
AQST
$471M
$3K ﹤0.01%
500
– –
AVXL icon
1224
Anavex Life Sciences
AVXL
$237M
$3K ﹤0.01%
314
– –
CRVS icon
1225
Corvus Pharmaceuticals
CRVS
$1.11B
$3K ﹤0.01%
400
– –
47 48
49
50 51

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q3 2025 Portfolio in Review

As of Q3 2025, Daiwa Securities Group held 1,385 positions worth $29.6B, up 9.4% from $27.1B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Daiwa Securities Group's Q3 2025 filing shows 83 new, 652 increased, 368 reduced and 52 closed positions. Its largest new stake was Eagle Materials: 54,795 shares worth $12.8M. The largest sale was Global X Conscious Companies ETF, an estimated $130M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Real Estate and Communication Services.

  • Daiwa Securities Group's largest Q3 2025 buy was Eagle Materials: 54,795 shares worth $12.8M.
  • Daiwa Securities Group added most to CrowdStrike in Q3 2025, an estimated $163M increase.
  • Daiwa Securities Group's biggest Q3 2025 reduction was Global X Conscious Companies ETF, cutting an estimated $130M.
  • Daiwa Securities Group fully exited Ansys in Q3 2025, selling an estimated $6.94M.
  • Daiwa Securities Group's ten largest holdings make up 36% of its $29.6B portfolio in Q3 2025.
  • Daiwa Securities Group opened 83 new positions and closed 52 in Q3 2025.
  • Daiwa Securities Group's portfolio value rose 9.4% quarter-over-quarter to $29.6B.

Based on Daiwa Securities Group's 13F filing for Q3 2025, filed 14 Nov 2025.